Page last updated: 2024-10-26

felodipine and Hyperplasia

felodipine has been researched along with Hyperplasia in 1 studies

Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Säfholm, C1
Havu, N1

Other Studies

1 other study available for felodipine and Hyperplasia

ArticleYear
General toxicity of the new calcium antagonist felodipine in dogs.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:7

    Topics: Adrenal Glands; Animals; Blood Cell Count; Blood Chemical Analysis; Calcium Channel Blockers; Dogs;

1993